Featured Research

from universities, journals, and other organizations

Steroid Nasal Spray More Effective Against Hay Fever

Date:
March 6, 2002
Source:
University Of Chicago Medical Center
Summary:
Researchers from the University of Chicago have found that the corticosteroid nasal spray fluticasone propionate (Flonase®) is slightly more effective at controlling seasonal allergies than a combination of two popular anti-allergy drugs: loratidine (Claritin®) and montelukast (Singulair®).

Researchers from the University of Chicago have found that the corticosteroid nasal spray fluticasone propionate (Flonase®) is slightly more effective at controlling seasonal allergies than a combination of two popular anti-allergy drugs: loratidine (Claritin®) and montelukast (Singulair®).

Related Articles


The study was presented March 4 at the 58th annual meeting of the American Academy of Allergy, Asthma and Immunology.

"Both approaches worked well with minimal side effects," said Robert Naclerio, M.D., professor of surgery at the University of Chicago and director of the study, "but in our small study the symptom scores were slightly better and the measures of inflammation were significantly better for those taking fluticasone.

"Because of the effect on inflammation, we prefer fluticasone," he added, "but for patients, the choice may come down to cost and whether they would prefer a pill or a spray."

Since one out of five people in the United States suffers from seasonal allergies, such preferences have financial implications. Antihistamines are prescribed three times as often, even though intranasal corticosteroids are less expensive than the non-sedating antihistamines. Combining loratidine with montelukast increases the cost difference.

A daily dose of Claritin, the leading antihistamine, costs $2.92 at the University of Chicago Hospitals pharmacy. Singulair, which works by blocking leukotrienes -- substances that trigger inflammation -- costs $4 per day. Flonase, the leading prescription nasal spray, costs $2.21 per day.

Since loratidine and montelukast are effective alone and act through different mechanisms, the makers of these drugs joined forces to combine them. The only published previous study found the two drugs together were somewhat more effective than either drug used alone. This study compared this combination against the popular nasal spray.

The researchers enrolled 60 patients with ragweed allergies in a randomized, double-blind, double-dummy study that lasted two weeks during the 2000 hay fever season in Chicago. The patients were matched for allergy severity and divided into two groups.

One group (29) received fluticasone once a day, plus placebo pills. The other group (31) received a placebo nasal spray plus loratadine and montelukast once a day.

Two weeks later, the nasal spray group reported a greater reduction of allergy symptoms -- such as sneezing, runny nose and congestion -- than the pill group. On a scale of zero (no symptoms) to 12 (severe symptoms), the fluticasone group had a median score of 4.5, while the loratadine/montelukast group had a score of 6.

On a quality-of-life survey, which looked at the impact of allergies on factors such as sleep, emotions and daily activities, the fluticasone group had significantly fewer allergy-related problems. Overall scores for the fluticasone group fell from 2.8 (on a scale of zero to seven) before the study to 1.4 after two weeks, while the loratadine/montelukast scores fell from 2.6 before the study to 1.7 after two weeks.

In addition, the nasal spray group had better scores for two biomarkers of an allergic reaction. They had fewer eosinophils -- a type of immune cell associated with allergies -- in their nasal passages at two weeks. They also had lower levels of eosinophil cationic protein, another sign of inflammation.

Side effects were minimal. Five of the 29 people on fluticasone and six of 31 on loratadine and montelukast complained of headache.

"Our study supports the addition of the combination of montelukast and loratadine to the clinician's choices for the treatment of seasonal allergic rhinitis," noted the authors. "But it also suggests," added Naclerio, "that fluticasone, which is less expensive, may be a better first choice."

A previous study by the same group found that the nasal spray was more effective than antihistamines when used as needed rather than daily throughout the allergy season.


Story Source:

The above story is based on materials provided by University Of Chicago Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Chicago Medical Center. "Steroid Nasal Spray More Effective Against Hay Fever." ScienceDaily. ScienceDaily, 6 March 2002. <www.sciencedaily.com/releases/2002/03/020306074352.htm>.
University Of Chicago Medical Center. (2002, March 6). Steroid Nasal Spray More Effective Against Hay Fever. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2002/03/020306074352.htm
University Of Chicago Medical Center. "Steroid Nasal Spray More Effective Against Hay Fever." ScienceDaily. www.sciencedaily.com/releases/2002/03/020306074352.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins